GlassScriptPhysician profile
Steven B Maron
NPI 1619266186
$42,007.43
in general payments reported to CMS, 2019-2025
13 companies · $11K in 2025
The $11K reported for 2025 was more than what 89% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2021: $4,559 · 2022: $14K · 2023: $1,262 · 2024: $1,017 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $770 · Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,417.25 |
| Travel and Lodging | $769.61 |
| Food and Beverage | $593.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14,949.80 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $10,842.68 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $9,542.83 | 2021-2022 | |
| Daiichi Sankyo INC. | $4,110.00 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $1,357.03 | 2023-2025 | |
| Beigene USA, INC. | $1,016.67 | 2024 | |
| Exelixis INC. | $108.35 | 2022 | |
| Genentech USA, INC. | $80.07 | 2022 |
5 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Maron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.